One of the explanations could be a high prevalence in this group of mild mutations such as ApoB mutations, which in general result in a less severe FH phenotype than LDLR mutations.[23] Indeed, we observe a non-significant trend towards a higher prevalence of ApoB among those without severe dyslipidemia in our study population. The gene discussed is APOB; the disease is familial hyperaldosteronism.